- $10.80bn
- $14.84bn
- $13.87bn
- 82
- 77
- 22
- 62
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 12,506 | 11,629 | 13,089 | 12,794 | 13,866 |
Cost of Revenue | |||||
Gross Profit | 4,852 | 4,593 | 5,322 | 5,223 | 5,579 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 11,609 | 10,656 | 11,638 | 11,213 | 12,510 |
Operating Profit | 897 | 973 | 1,451 | 1,581 | 1,356 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 791 | 885 | 1,399 | 1,518 | 1,235 |
Provision for Income Taxes | |||||
Net Income After Taxes | 576 | 635 | 1,069 | 1,133 | 929 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 541 | 638 | 1,091 | 1,149 | 936 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 541 | 638 | 1,091 | 1,149 | 936 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.93 | 2.29 | 3.77 | 3.75 | 3.71 |
Dividends per Share |